I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Zinc pyrithione is a potent inhibitor of PLPro and cathepsi..:
Kladnik, Jerneja
;
Dolinar, Ana
;
Kljun, Jakob
...
Journal of Enzyme Inhibition and Medicinal Chemistry;37(1). , 2022
Link:
https://hdl.handle.net/11351/8644
RT Journal T1
Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
UL https://suche.suub.uni-bremen.de/peid=base-ftscientia:oai:scientiasalut.gencat.cat:11351_8644&Exemplar=1&LAN=DE A1 Kladnik, Jerneja A1 Dolinar, Ana A1 Kljun, Jakob A1 Perea Pérez, David A1 Grau Exposito, Judit A1 Genesca Ferrer, Meritxell A1 Novinec, Marko A1 Buzón Gómez, María José A1 Turel, Iztok PB Taylor & Francis YR 2022 K1 COVID-19 (Malaltia) - Tractament K1 Medicaments antivírics - Ús terapèutic K1 Compostos organometàl·lics K1 DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections K1 Other subheadings::Other subheadings::Other subheadings::/drug therapy K1 CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents K1 CHEMICALS AND DRUGS::Organic Chemicals::Organometallic Compounds K1 ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus K1 Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia K1 COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antivíricos K1 COMPUESTOS QUÍMICOS Y DROGAS::compuestos orgánicos::compuestos organometálicos JF Journal of Enzyme Inhibition and Medicinal Chemistry;37(1) LK http://dx.doi.org/https://hdl.handle.net/11351/8644 DO https://hdl.handle.net/11351/8644 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)